Rights and permissions
About this article
Cite this article
Imatinib mesylate induces sustained complete molecular remission in a patient with chronic myeloid leukaemia. Inpharma Wkly. 1352, 12 (2002). https://doi.org/10.2165/00128413-200213520-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213520-00024